DB07268 is a potent and selective JNK1 inhibitor with an IC50 value of 9 nM.
사양
동의어
2-((2-(3-Hydroxyanilino)pyrimidin-4-yl)amino)benzamide | 4-anilinopyrimidine 2b | 2-((2-((3-Hydroxyphenyl)amino)pyrimidin-4-yl)amino)benzamide | 2-[[2-(3-hydroxyanilino)pyrimidin-4-yl]amino]benzamide | 2-(4-(3-hydroxyphenylamino)pyrimidin-2-ylamino)benzamide | 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE | Benzamide, 2-((2 Show more
사양 및 순도
≥98%
생화학 및 생리적 메커니즘
This compound has some degree of selectivity over quite a few kinases with the exceptions of CHK1, CK2, and PLK. Although compound 2b(DB-07268) shows submicromolar potency against these three kinases, it still appears to exhibit at least 70- to 90-fold greater potency against JNK1 than CHK1, CK2, and PLK.
This compound belongs to the class of organic compounds known as benzamides. These are organic compounds containing a carboxamido substituent attached to a benzene ring.
External Descriptors
aminopyrimidine - benzamides
1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.